Objective: We compared white blood cells parameters (total white blood cells (WBC), lymphocytes count (LYMPH#) and percentage (LYMPH%), monocytes count (MONO) and percentage (MONO%), basophils count (BASO#) and percentage (BASO%), eosinophils count (EO#) and percentage (EO%), neutrophils count (NEUT#) and percentage (NEUT%)) in patients with schizophrenia (SHZ), unipolar depression (UD) and bipolar disorder (BIP): bipolar depression (BD) and mania (BM).
INTRODUCTION
Leukocytes are the cells that circulate in the bloodstream and are divided into following subtypes: neutrophils, lymphocytes, basophils, eosinophils, and monocytes. White blood cell count (WBC) is the number of leukocytes per unit volume in venous blood, while differential leukocytes count represents the relative numbers of their subtypes. WBC helps to detect hematological abnormalities, but mainly it is a part of basic health check-up in patients either admitted to the hospital or presenting to primary care.
A reference range stands for the set of values within which 95 percent of the normal population falls. Therefore, it is interpreted as the range of values for a physiologic measurement in healthy individuals [1] . Normal values may vary depending on the assay used by laboratory. Moreover, among factors influencing WBC are: infections, autoimmunological disorders, splenomegaly and splenectomy, but also age (complex dependence, conflicting results) [2, 3] , medications [3, 4] , body weight (positive correlation)
Archives of Psychiatry and Psychotherapy, 2017; 3: 16-26 [3, 5, 6] , smoking (positive correlation) [2, 7] , alcohol consumption (inverse association) [3, 8] , exposure to benzene (leukocytopenia) [2] . Sun et al. concluded that subnormal WBC counts (<3.9 × 10 9 cells/L), which rather exclude even lowgrade systemic inflammation, are related to the lower prevalence of metabolic syndrome and the lowest incidence of metabolic syndrome during a 5-year follow-up period among healthy population than WBC counts within reference range [9] . Metabolic alterations are particularly common in patients treated with antipsychotics [10] . In this group around 50% suffer from metabolic disorders, which significantly reduces the lifespan and life quality. So far, studies show that a higher total leukocyte count is a predictor of all-cause mortality and cardiovascular morbidity [11] . Fan et al. suggested that higher white blood cell counts are associated not only with an increased risk for metabolic syndrome, but also more severe psychopathology in patients suffering from schizophrenia [12] .
Schizophrenia, unipolar depression and bipolar disorder are severe psychiatric disorders affecting millions of people worldwide. Their complex etiology and pathophysiology are still not satisfactory elucidated, therefore there is a plethora of research examining their psychopathology. Moreover mental illnesses cause great human and economic costs. Alterations in inflammatory system have been suggested as be associated with psychiatric disorders, and white blood cells are important components of it.
The aim of the study is to investigate if there are any differences in white blood cells parameters among patients with schizophrenia, unipolar depression, bipolar depression and bipolar mania.
MATERIAL AND METHODS
This was a retrospective, cross-sectional, naturalistic study. From our psychiatric hospital computer database, we have selected data for Caucasian patients with the diagnosis of schizophrenia, bipolar disorder or unipolar depression, aged 18 or more, both men and women. Only the first entry for each patient was used for analysis. The following data were collected: age, sex, diagnosis and white blood cell parameters.
Patients were grouped under diagnostic criteria as schizophrenia (F20 according to ICD-10, 295 according to DSM-IV), unipolar depression (F31 and F32 according to ICD-10, 296.2 and 296.3 according to DSM-IV), bipolar disorder (F30 and F31 according to ICD-10, 296.[0, 4, 6] according to DSM-IV), which included: bipolar depression (F31.3-F31.5 according to ICD-10, 296.6 according to DSM-IV) and bipolar mania (F30 and F31.0-F31.2 according to ICD-10, 296.0 and 296.4 according to DSM-IV). In our unit diagnosis is based on the ICD-10 criteria, DSM-IV codes were given as reference. All diagnostic codes are based on discharge diagnosis.
For all patients in our study blood samples were collected into tubes with anticoagulant between 8 and 9 a.m. after 12 hours overnight fast. Usually the first blood test is done next day after admission to our units. Therefore, we have assumed that most patients that we included in the study were in acute phase of their disorder. Immediately after collecting blood samples, complete blood count was determined using Sysmex XS-1000i TM Automated Hematology Analyzer (Sysmex, USA). The following white blood cell parameters were measured: white blood cell count (WBC, expressed in × 10 3 /mm 3 ), lymphocyte count (LYMPH#, expressed in × 10 3 /mm 3 ), lymphocyte percentage (LYMPH%, expressed in %), monocyte count (MONO#, expressed in × 10 ) and neutrophil percentage (NEUT%, expressed in %). Table 1 shows our laboratory reference ranges used in the analysis. Statistical procedures were performed with STATA 13.1 (StataCorp, USA). Simple descriptive statistics (mean±standard deviation) were generated for continuous variables. For discrete variables number of patients and percentages are given. Normality of distribution was tested with Shapiro-Wilk test. While some variables did not follow normal distribution, due to large sample size we used one-way ANOVA with post-hoc Tukey test and t-test. The difference between proportions was analyzed with the chi-square test. Associations were tested by Spearman's correlation coefficient. Odds ratios (OR) with 95% confidence intervals (CI) were calculated using logistic regression adjusted for age. The level of significance was set at p <0.05.
The study has been approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
RESULTS
In the study group of 2381 patients included in the analysis there were 60.0% women (n = 1429). The proportion of women in the schizophrenia group (n = 1244) was 46.9% (n = 583), 76.3% (n = 606) in the unipolar depression group (n = 794), 70.0% (n = 240) in the bipolar disorder group (n = 343), 72.2% (n = 187) in the bipolar depression group (n = 259), 63.1% (n = 53) in the bipolar mania (n = 84), see Figure 1 . The difference between the groups in the proportion of women was significant (Χ 2 = 194.0, df = 3, p <0.001), with the lowest proportion of women in the schizophrenia group. In the schizophrenia group there were 4 patients with hebephrenic subtype, 5 with residual schizophrenia and 2 with simple-type schizophrenia. These subgroups were too small to include them into separate analysis and therefore we decided to combine all patients with schizophrenia into one group. The age of the study group was 45.6±19.6 years. Mean age in the subgroups was: schizophrenia 40.3±16.2, unipolar depression 51.4±22.3, bipolar depression 52.6±18.2, bipolar mania 46.0±19.2 years. One-way ANOVA showed that there were significant age differences between the groups (p <0.001) with patients in the unipolar depression, bipolar depression and bipolar mania groups being significantly older (p <0.001 for all comparisons; Tukey post-hoc test). Age distribution in the study sample is shown in Figure 1 and Table 2 . Mean values of leukocyte parameters are given in Table 3 , with significant (p <0.05) intergroup differences for most parameters. Posthoc analysis using the Tukey test revealed that patients with schizophrenia had higher WBC than patients with unipolar depression (p = 0.04), patients with bipolar depression had LYMPH% higher than patients with schizophrenia (p = 0.001), bipolar mania (p = 0.017) and unipolar depression (p = 0.003), while patients with unipolar depression had EO% higher than patients with schizophrenia (p = 0.008). For the whole study group there was a significant differences between men and women for WBC (6.93±2.00 vs. 6 Table 4 shows distribution of low, normal and high ranges of blood cells parameters in the study groups. Patients with bipolar mania had the highest percentage of abnormal results for WBC (both below and above normal range -8.3% and 7.1%, respectively), MONO% below normal range (17.9%) and NEUT# below normal range (9.2%). Patients with schizophrenia had the highest percentage of NEUT# above normal range (12.7%). There were no significant intergroup differences for other hematological parameters. Apart from neutrophils and eosinophils, patients with WBC, LYMPH#, LYMPH%, MONO#, MONO% below normal range were significantly older (p <0.01 for all variables). Patients with BASO# and BASO% above normal range were significantly older (p <0.001 for both variables), no differences were found for the remaining white blood cells parameters being above normal range. Table 5 shows correlations between hematological parameters and age in diagnostic groups. Also, we tested several regression models for red blood cells parameters and calculated odds ratios for hematological parameters being below or above normal values. All models were adjusted for sex and age, with the schizophrenia group as the reference. For WBC no variables were statistically significant in the model. For LYMPH# age was statistically significant in the model (p <0.001, R 2 = 0.015) and was associated with decreased (regression coefficients β = -0.12) value. For LYMPH% age and diagnosis of bipolar depression were statistically significant in the Archives of Psychiatry and Psychotherapy, 2017; 3: [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] model (p <0.001, R 2 = 0.01), with age associated with decreased (β = -0.09) and bipolar depression associated with increased (β = 0.1) value. For MONO# and MONO% sex was statistically significant in the model (p <0.001, respectively; R 2 = 0.01), with male sex associated with increased value (β = 0.01 and 0.09). For BASO# age and diagnosis of bipolar depression were statistically significant in the model (p <0.05, R 2 = 0.01), with age associated with increased (β = 0.09) and bipolar depression associated with increased (β = 0.05) value. For BASO% age was statistically significant in the model (p <0.001, R 2 = 0.01) and was associated with increased (β = -0.1) value. For EO# and EO% sex and diagnosis of bipolar mania and unipolar depression were statistically significant in the model (p <0.05, R 2 = 0.02), with male sex and bipolar mania or unipolar depression associated with increased value (for EO# β = 0.12, 0.05 and 0.08, respectively; for EO% β = 0.12, 0.06 and 0.12, respectively). For NEUT# diagnosis of bipolar depression was statistically significant in the model (p = 0.04, R 2 <0.01) and was associated with decreased (β = -0.05) value. Finally, for NEUT% age and diagnosis of bipolar depression were statistically significant in the model (p = 0.03 and 0.001, respectively; R 2 = 0.01), with age associated with increased value (β = 0.05) and bipolar depression associated with decreased value (β = -0.08). Note that all R 2 and beta values are very low, indicating little effect of these variables.
For WBC below normal value male sex was as- 
DISCUSSION
The objective of this study was to investigate if there are any differences in white blood cells parameters in a large sample (n = 2381) of patients with acute phase of schizophrenia, unipolar depression, bipolar depression and bipolar mania. We have confirmed that there were differences for several analyzed parameters.
As reported by previous studies, higher total leukocyte count may predict increased risk of metabolic syndrome and cardiovascular mortality and morbidity [11] . Highest total number of white blood cells was found in the schizophrenia and bipolar mania groups. This observation would indicate that these two groups of patients should be particularly carefully observed for metabolic alterations. Patients with schizophrenia had highest (although non-significant) mean value of absolute neutrophil count. Also, the percentage of patients with below norm value of absolute neutrophil count was lowest in the schizophrenia group and highest in the bipolar disorder group (both mania and depression). Patients with bipolar mania had lowest number of lymphocytes (both absolute and percentage) and highest number of eosinophils (both absolute and percentage). Highest frequency of below or above normal value of white blood cells was found in patients with bipolar mania. In our study, higher neutrophil/lymphocyte ratios (NLR) were found in SHZ (1.75) and bipolar mania (1.71) groups and lower in bipolar depression (1.52) group. In patients with schizophrenia elevated neutrophil/lymphocyte ratio was observed (SHZ vs. healthy controls: 2.6 vs. 1.9; p <0.001) [13] . Other authors observed high-er NLR in patients with bipolar disorder [14] . As there is no healthy controls in our study it is difficult to compare those study findings. There were also numerous age -and gender-related differences for the majority of parameters.
Inflammatory process has been suggested as a risk factor as well as underlying cause of psychiatric disorders, hence inflammation has become a putative pharmacological target. Inflammatory parameters (e.g., C-reactive protein -CRP and white blood count as easily available and routinely collected in patients) have been examined in psychiatric patients. Recent population-based study by Horsdal et al. has shown that CRP differed across mental disorders, while WBC did not differ. Moreover elevated values of CRP were associated with increased mortality in psychiatric population, while values of WBC were not associated with mortality [15] .
Moreover, effectiveness and tolerance of antiinflammatory agents (e.g., omega 3 polyunsaturated fatty acids (PUFA), celecoxib, minocycline, N-acetylcysteine, pioglitazone, TNF-alpha antagonists) have been widely investigated in psychiatric population [16] [17] [18] [19] [20] . Recent meta-analyses indicated moderate antidepressant effect of adjunctive anti-inflammatory agents (N-acetyl cysteine, PUFA, celecoxib) in the treatment of bipolar depression [16, 20] . So far studies have demonstrated some effectiveness of PUFAs, Anti-TNF-alpha and celecoxib in treatment of unipolar depression, and minocycline in treatment of schizophrenia [21] .
Furthermore, it has been suggested that patients with high (>5 mg/l) concentration of C-reactive protein (CRP) may be particularly responsive to anti-inflammatory drugs [22] . No cut-off values for white blood count that could determinate patients who could benefit from anti-inflammatory treatment have been proposed. There are study findings indicating significant change in CRP and WBC during treatment with traditional antidepressants [23, 24] . Further research could evaluate potential change of WBC values during anti-inflammatory treatment of mental illnesses. Study by Miller et. al. indicated that WBC may be a predictor of an elevated 10-year estimated risk of myocardial infarction, which underlines significance of WBC in assessment of cardiovascular risk in schizophrenia patients [25] .
Our study has some limitations, which result from its cross-sectional and naturalistic design, as well as lack of control group. We only have data representing current white blood cells parameters and have no information regarding presence of past hematological abnormalities. White blood cells parameters may also result from other factors, which could not be included in the analysis, such as detailed inflammatory status of individuals (e.g., levels of other inflammatory biomarkers, subtypes of lymphocytes), exposure to ionizing radiation [26] , nutritional status [27, 28] , lifestyle [29] , duration of disease [13, [30] [31] [32] , etc. which also may have a significant impact on white blood cells parameters. Comorbidities (such as hypertension or extrapyramidal syndrome) were not an exclusion criterion. Participants of the study presented a number of comorbidities, but detailed and reliable data on co-occurring disorders were not available and therefore were not included into the analysis. Moreover, due to large study samples we believe that the distribution of major comorbidities and other factors that affect white blood cells parameters became comparable across the study groups and therefore should not affect observed differences. Results of rating scales for psychiatric conditions were not analyzed as we focused mainly on clinical diagnoses. Diagnostic groups were not homogenous, there were fewer women in the schizophrenia group comparing to other groups, while patients with unipolar and bipolar depression were significantly older comparing to other groups. Also, the bipolar disorder group was smaller comparing to schizophrenia and unipolar disorder (this is particularly true for bipolar mania group). These factors may affect results of intra -and inter-group comparisons. On the other hand, the large sample size and ability to compare tree major clinical groups (schizophrenia, unipolar disorder and bipolar disorder) are strengths of the study. Also, there are no studies comparing differences in white blood cells parameters between these diagnostic groups.
In conclusion, our study showed that there are differences in white blood cells parameters between schizophrenia, unipolar depression and bipolar disorder (both in manic and depressive episode). Total and differential white blood cell count are laboratory tests performed routinely, that is why their thoughtful interpretation is crucial. Since many psychiatric patients are at increased risk of white blood cells parameters alterations due to treatment (such as neutropenia during clozapine treatment), monitoring for abnormal white cells status is recommended. Figures 1a, 1b: Distribution of subjects and distribution of age (in years) in study groups.
